Chronomodulated delivery schedule of oxaliplatin, 5 fluorouracil and folinic acid (FFL4/10) as first line treatment in metastatic colorectal cancer: Preliminary data of a phase II study ...
Clinical-stage biotech company PharmAbcine is advancing its lead antibody candidate olinvacimab through the clinic, alone and in combination, whilst developing a portfolio of clinical candidates that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results